Published in Lancet on February 22, 1975
Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis. Gut (1978) 1.73
Cancer of the liver and the use of oral contraceptives. Br Med J (Clin Res Ed) (1986) 1.49
Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc Natl Acad Sci U S A (2007) 1.41
Hepatic tumours induced by anabolic steroids in an athlete. J Clin Pathol (1988) 1.12
Hepatic adenomas and oral contraceptives. Gut (1975) 1.11
Hepatitis B virus infection and primary hepatocellular carcinoma. Clin Microbiol Rev (1992) 1.04
Endocrine studies in Fanconi's anaemia. Report of 4 cases. Arch Dis Child (1978) 0.92
Metabolic effects of anabolic steroids. Br J Sports Med (1975) 0.91
Androgen associated hepatocellular carcinoma with an aggressive course. Gut (1991) 0.87
Hepatic reactions to drugs. Gut (1979) 0.85
Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States. Int J Mol Sci (2016) 0.81
The role of the pathologist in environmental medicine and public health. Am J Pathol (1977) 0.81
Hepatocellular carcinoma in a noncirrhotic liver after long-term use of danazol for hereditary angioedema. Case Rep Oncol (2014) 0.81
Haematogenous abdominal wall metastasis of differentiated, alpha-fetoprotein-negative hepatocellular carcinoma after previous antiandrogen therapy within a site of lipoma manifestation since childhood. World J Surg Oncol (2012) 0.78
The influence of high serum testosterone levels on the long-term prognosis in male patients undergoing hepatectomy for early stage hepatocellular carcinoma without vascular invasion. World J Surg (2007) 0.77
Hepatic lesions in patients treated with synthetic anabolic steriods. J Clin Pathol (1976) 0.77
Oral contraceptives and liver tumours. Proc R Soc Med (1976) 0.75
Mechanism of antigen-driven selection in germinal centres. Nature (1990) 5.26
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest (2000) 3.17
Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis (2001) 2.63
Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways. Development (2000) 2.39
Hepatitis C virus in intravenous drug users. Med J Aust (1990) 2.33
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology (1998) 2.19
The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C. Med J Aust (1994) 2.15
A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol (1978) 2.04
The parathyroid hormone/parathyroid hormone-related peptide receptor coordinates endochondral bone development by directly controlling chondrocyte differentiation. Proc Natl Acad Sci U S A (1998) 1.94
Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res (1995) 1.87
Binocular single vision and depth discrimination. Receptive field disparities for central and peripheral vision and binocular interaction on peripheral single units in cat striate cortex. Exp Brain Res (1970) 1.84
Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology (1996) 1.83
Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol (2001) 1.79
Which patients with hepatitis C develop liver complications? Hepatology (2000) 1.73
Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation. Br J Obstet Gynaecol (1985) 1.71
Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg (1999) 1.68
Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development. Development (1998) 1.64
Lymphatic mapping and sentinel node biopsy for melanoma. Expert Rev Anticancer Ther (2001) 1.45
Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival. Blood (2001) 1.45
Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment. Intern Med J (2008) 1.43
Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C. Hepatology (1995) 1.41
Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetron. Ann Oncol (1992) 1.39
Gallium-67 and technetium-99m-methylene diphosphonate skeletal scintigraphy in determining prognosis for children with stage IV neuroblastoma. J Nucl Med (1993) 1.38
Confusion, cortical blindness and fever. Med J Aust (1995) 1.38
Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood (2001) 1.37
Serological evidence for the association of papillomavirus and cervical neoplasia. Lancet (1983) 1.35
Globin genes in Polynesians have many rearrangements including a recently described gamma gamma gamma gamma/. Am J Hum Genet (1986) 1.34
Uremic cardiomyopathy--effect of hemodialysis on left ventricular function in end-stage renal failure. N Engl J Med (1980) 1.33
The CREB family of activators is required for endochondral bone development. Development (2001) 1.31
Enhanced drug metabolism in cigarette smokers. Br Med J (1976) 1.31
Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastroenterol Hepatol (2000) 1.19
Role of ischemia and infarction in late right ventricular dysfunction after atrial repair of transposition of the great arteries. J Am Coll Cardiol (2000) 1.19
Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology (1995) 1.18
Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study Group. Blood (1990) 1.17
Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance. Blood Cancer J (2013) 1.17
Studies on phospholipids in the action of a lupus coagulation inhibitor. Pathology (1975) 1.16
Popliteal lymph node metastasis from primary cutaneous melanoma. Eur J Surg Oncol (2000) 1.16
Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes. Clin Pharmacol Ther (1979) 1.13
Drug-induced cholestasis. Semin Gastrointest Dis (2001) 1.13
Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. J Neurol Neurosurg Psychiatry (1991) 1.13
Patterns of abnormality on bone scans in acute childhood leukemia. J Nucl Med (1998) 1.12
Identification of beta variant hemoglobins by DNA restriction endonuclease mapping. Hemoglobin (1984) 1.11
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice. Br J Cancer (2012) 1.10
Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab (1998) 1.07
Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats. Biochem Biophys Res Commun (1999) 1.06
Effects of hepatitis G virus coinfection on severity of hepatitis C: relationship to risk factors and response to interferon treatment. J Gastroenterol Hepatol (1998) 1.06
Alpha globin gene rearrangements in Polynesians are not associated with malaria. Am J Hematol (1985) 1.03
Cold agglutinin formation in patients undergoing haemodialysis. A possible relationship to dialyser re-use. Aust N Z J Med (1975) 1.02
Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat (1995) 1.01
Does hepatitis C virus play a role in "non-viral" chronic liver disease? Med J Aust (1990) 1.01
Inhibition of theophylline metabolism by interferon. Lancet (1987) 1.01
Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism. Gastroenterology (1978) 1.01
Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg (1995) 1.00
Incorporation of exogenous heme into hepatic cytochrome P-450 in vivo. J Biol Chem (1979) 0.99
Immunosuppression in BALB/c mice bearing the plasmacytoma TEPC-183: massive increase in red pulp macrophages induced by the tumour. Immunology (1980) 0.99
Localization of coronary artery disease with exercise electrocardiography: correlation wit thallium-201 myocardial perfusion scanning. Am J Cardiol (1981) 0.98
Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. J Viral Hepat (2008) 0.98
Epitrochlear lymph nodes as a site of melanoma metastasis. Ann Surg Oncol (1998) 0.96
T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells. Br J Haematol (2000) 0.96
Management of chronic hepatitis C virus infection: a new era of disease control. Intern Med J (2004) 0.95
Pre-translational regulation of cytochrome P450 genes is responsible for disease-specific changes of individual P450 enzymes among patients with cirrhosis. Biochem Pharmacol (1995) 0.95
Chronic consumptive coagulopathy with a uterine leiomyoma. Aust N Z J Obstet Gynaecol (1982) 0.94
Role of oxidative stress in hypoxia-reoxygenation injury to cultured rat hepatic sinusoidal endothelial cells. Hepatology (2000) 0.94
Cost effectiveness of the all-digital nuclear medicine department. Radiology (1983) 0.93
Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: evidence from the Ig heavy chain gene. Blood (1993) 0.93
Idiopathic acute fatty liver of pregnancy. Gut (1970) 0.92
Does steatohepatitis impair liver regeneration? A study in a dietary model of non-alcoholic steatohepatitis in rats. J Gastroenterol Hepatol (1999) 0.92
Radionuclide left ventriculography with the slant hole collimator. J Nucl Med (1977) 0.92
Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients. Melanoma Res (1997) 0.92
Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. AJR Am J Roentgenol (1998) 0.91
Squamous cell carcinoma in situ arising in inflammatory cloacogenic polyps: report of two cases with PCR analysis for HPV DNA. Pathology (2001) 0.91
High discordance rates between sub-areolar and peri-tumoural breast lymphoscintigraphy. Eur J Surg Oncol (2013) 0.91
Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver. Biochem Pharmacol (1995) 0.91
Mechanism of azathioprine-induced injury to hepatocytes: roles of glutathione depletion and mitochondrial injury. J Hepatol (2001) 0.91
Is staging laparotomy necessary in patients with supradiaphragmatic stage I and IIA Hodgkin's disease? Lancet (1984) 0.90
Analysis of N-ras gene mutations in acute myeloid leukemia by allele specific restriction analysis. Am J Hematol (1991) 0.90
Erysipelothrix endocarditis. Med J Aust (1975) 0.89
Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes. Hepatology (1996) 0.89
Influence of clinicopathological variables on CYP protein expression in human liver. J Gastroenterol Hepatol (1996) 0.89
Structural and functional reconstitution of hepatic cytochrome P-450 in vivo. Reversal of allylisopropylacetamide-mediated destruction of the hemoprotein by exogenous heme. J Biol Chem (1980) 0.89
Assessment of regional cerebral blood flow (rCBF) in stroke using SPECT and N-isopropyl-(I-123)-p-iodoamphetamine (IMP). Stroke (1984) 0.88
Detection of variants of haemoglobin D in Australia: haemoglobin D Camperdown alpha 2 A beta 2 121 Glu leads to Val and haemoglobin D Punjab alpha 2 A beta 2 121 Glu leads to Gin. Med J Aust (1974) 0.88
Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes. Med J Aust (1994) 0.88
Hepatotoxicity from paracetamol self-poisoning in western Sydney: a continuing challenge. Med J Aust (1992) 0.88
Comparison of thallium-201 scanning in idiopathic dilated cardiomyopathy and severe coronary artery disease. Circulation (1982) 0.88
Prediction of response to plasma exchange in chronic relapsing polyneuropathy. A clinico-pathological correlation. J Neurol Sci (1983) 0.88
Single daily ceftriaxone and tobramycin in the empirical management of febrile neutropenic patients: a randomised trial. Int J Hematol (1993) 0.87
Cytochrome P-450 heme moiety. The specific target in drug-induced heme alkylation. J Biol Chem (1981) 0.87
A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemia. Aust N Z J Med (1986) 0.87
Interferon suppresses erythromycin metabolism in rats and human subjects. Hepatology (1993) 0.87
Immune suppression in BALB/c mice bearing the plasmacytoma TEPC-183: evidence for normal lymphocyte but defective macrophage function. Int J Cancer (1979) 0.87
Drug metabolism in cirrhosis. Selective changes in cytochrome P-450 isozymes in the choline-deficient rat model. Biochem Pharmacol (1986) 0.87
T cells in myeloma. Hematol Oncol (2003) 0.87
The effects of cell density, attachment substratum and dexamethasone on spontaneous apoptosis of rat hepatocytes in primary culture. In Vitro Cell Dev Biol Anim (1999) 0.86
The central role of sinusoidal endothelial cells in hepatic hypoxia-reoxygenation injury in the rat. Hepatology (1996) 0.86
Accuracy and clinical utility of simplified tests of antipyrine metabolism. Br J Clin Pharmacol (1984) 0.86